Skip to content

Management and Outcomes of Perioperative Care Among European Diabetic Patients

Management and Outcomes of Perioperative Care Among European Diabetic Patients: (MOPED): A Prospective Observational, International Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04511312
Enrollment
5000
Registered
2020-08-13
Start date
2021-05-01
Completion date
2024-08-31
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Postoperative Complications

Keywords

Diabetes Mellitus, Surgery, Postoperative complications

Brief summary

The incidence of diabetes is increasing globally, including within Europe. There is an estimated 20million diabetic patients in Europe, which is likely to increase, thereby adding to societal demands on European health services. Diabetic patients are more likely to have surgical interventions than the general population. There are plausible pathophysiology and clinical mechanisms that diabetics are at increased risk of postoperative complications. When postoperative complications occur in the general population, they increase mortality or increase risk of major adverse cardiovascular events (Myocardial Infarction, Cerebrovascular Accident, Pulmonary embolism) at 30-days and up to one year later. In addition, diabetes is an independent risk factor for surgical site infections. There is variation in practice guidelines in different countries in the perioperative management of diabetic patients undergoing major surgery, but this has not been documented on a large scale. Given the multiplicity of guidelines and differing recommendations, it is unsurprising that variability of 'real-world' clinical practice with regard to perioperative management of oral antihyperglycemic medications and insulin therapy has been noted in audits such as the National Confidential Enquiry into Patient Outcome and Death (NCEPOD). Further, although it is recognised that diabetic patients are at increased risk of postoperative complications, this has not been recently evaluated, especially in light of ongoing developments in perioperative care, such as Enhanced Recovery Programmes. While a quality improvement intervention study has shown that maintaining tight preoperative glycaemic control improves postoperative glycaemic control, it is not known if this reduces postoperative morbidity overall. Further, whether certain anaesthetic techniques may be associated with better or worse outcomes after major non-cardiac surgery is unknown.

Detailed description

see brief summary

Interventions

None listed

Sponsors

European Society of Anaesthesiology
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Diabetic patients (all classes except gestational diabetes) undergoing surgery (defined as requiring any general anaesthesia technique or any specific regional anaesthetic technique or a combination) * Ambulatory, elective or emergency surgery and patients who receive postoperative care in intensive care or high dependency units will be included.

Exclusion criteria

* Patients who are not diabetic * Patients with gestational diabetes * Patients undergoing minor surgery

Design outcomes

Primary

MeasureTime frameDescription
Days at Home at 30 Days after surgery (DAH-30)30 daysNumber of days at home in the 30 days post surgery

Secondary

MeasureTime frameDescription
Comprehensive Complications Index (CCI) score, based on Clavien-Dindo scale;Day 30Minimum score 0; Maximum score 100. Higher score indicates worse complications
Quality of Recovery QoR-15 measuring quality of recovery on Day 1 onlyDay 1Minimum score 0; Maximum score 150. Higherscore indicates better recovery.

Countries

Ireland

Contacts

Primary Contactsaman Homayun Sepehr, Master
saman.sepehr@esahq.org3222273999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026